tert-Butyl (3R,4S)-3-Amino-4-methylpyrrolidine-1-carboxylate - CAS 1152113-30-8
Catalog: |
BB057718 |
Product Name: |
tert-Butyl (3R,4S)-3-Amino-4-methylpyrrolidine-1-carboxylate |
CAS: |
1152113-30-8 |
Synonyms: |
tert-butyl (3R,4S)-3-amino-4-methylpyrrolidine-1-carboxylate; (3R,4S)-1-Boc-3-amino-4-methylpyrrolidine; (3R,4S)-rel-tert-Butyl 3-amino-4-methylpyrrolidine-1-carboxylate; trans-1-boc-3-amino-4-methylpyrrolidine; tert-butyl trans-3-amino-4-methylpyrrolidine-1-carboxylate; (3R,4S)-tert-Butyl 3-amino-4-methylpyrrolidine-1-carboxylate; 1-Pyrrolidinecarboxylic acid, 3-amino-4-methyl-, 1,1-dimethylethyl ester, (3R,4S)-rel- |
IUPAC Name: | tert-butyl (3R,4S)-3-amino-4-methylpyrrolidine-1-carboxylate |
Description: | tert-butyl (3R,4S)-3-amino-4-methylpyrrolidine-1-carboxylate (cas# 1152113-30-8) is a useful research chemical. |
Molecular Weight: | 200.27 |
Molecular Formula: | C10H20N2O2 |
Canonical SMILES: | CC1CN(CC1N)C(=O)OC(C)(C)C |
InChI: | InChI=1S/C10H20N2O2/c1-7-5-12(6-8(7)11)9(13)14-10(2,3)4/h7-8H,5-6,11H2,1-4H3/t7-,8-/m0/s1 |
InChI Key: | DUBXUUPBIKNFEA-YUMQZZPRSA-N |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021215545-A1 | Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl)-1h-imidazole-5-carboxamide inhibitor of kras-g12c | 20200424 |
US-2021269434-A1 | Tricyclic compounds as inhibitors of kras | 20200110 |
WO-2021142252-A1 | Tricyclic compounds as inhibitors of kras | 20200110 |
WO-2020123925-A1 | Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof | 20181214 |
CA-3115126-A1 | Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof | 20181214 |
AU-2019395255-A1 | Pyrazolopyridine inhibitors of c-Jun-N-terminal kinases and uses thereof | 20181214 |
CN-113164477-A | Pyrazolopyridine inhibitors of C-JUN-N-terminal kinase and uses thereof | 20181214 |
EP-3893879-A1 | Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof | 20181214 |
JP-2022513846-A | Pyrazolopyridine inhibitors of C-JUN-N terminal kinases and their use | 20181214 |
US-2022073512-A1 | Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof | 20181214 |
Complexity: | 223 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 2 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 200.152477885 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 200.152477885 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 55.6Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS